Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR‐AKT‐mTOR signaling

Author:

Lee Kang‐Yun12,Shueng Pei‐Wei345,Chou Chih‐Ming67,Lin Bo‐Xing67,Lin Mei‐Hsiang8,Kuo Deng‐Yu3,Tsai I‐Lin679,Wu Sheng‐Ming12,Lin Cheng‐Wei67910ORCID

Affiliation:

1. Division of Pulmonary Medicine Department of Internal Medicine Shuang Ho Hospital Taipei Medical University New Taipei City Taiwan

2. Division of Pulmonary Medicine Department of Internal Medicine School of Medicine College of Medicine Taipei Medical University Taipei Taiwan

3. Division of Radiation Oncology Far Eastern Memorial Hospital New Taipei City Taiwan

4. Faculty of Medicine School of Medicine National Yang‐Ming University Taipei Taiwan

5. Department of Radiation Oncology Tri‐Service General Hospital National Defense Medical Center Taipei Taiwan

6. Department of Biochemistry and Molecular Cell Biology School of Medicine College of Medicine Taipei Medical University Taipei Taiwan

7. Graduate Institute of Medical Sciences College of Medicine Taipei Medical University Taipei Taiwan

8. Graduate Institute of Pharmacy College of Pharmacy Taipei Medical University Taipei Taiwan

9. Center for Cell Therapy and Regeneration Medicine Taipei Medical University Taipei Taiwan

10. Cell Physiology and Molecular Image Research Center Wan Fang Hospital Taipei Medical University Taipei Taiwan

Funder

Ministry of Science and Technology, Taiwan

Taipei Medical University

Far Eastern Memorial Hospital

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3